cvs glp-1 news Restores Coverage of Lilly's Zepbound, Adds Oral Obesity Drug Foundayo CVS Caremark sued over GLP-1
Description
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Turn Healthy Behaviors Into Lasting Habits
Sweet satisfaction
Study outcomes included the number needed to treat (NNT) to prevent one case of clinical events, healthcare costs, and cost per case of event prevented
A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to patients taking another diabetes medication, DPP-4 inhibitors
